Many stock analysts see Indianapolis-based Elevance’s recent struggles as an opportunity. Thirteen of 24 analysts tracked by The Wall Street Journal rate the health insurer as a buy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback